US equities |
NVDA $240.43 ▲+0.64% SPCX $173.02 ▲+1.13% MU $1,066.56 ▲+0.24% MRVL $288.68 ▲+6.43% AMD $655.27 ▲+3.72% INTC $115.12 ▼-0.92% AVGO $379.29 ▲+4.63% TSLA $380.26 ▲+0.41%
FinancialContent

Latest News about Neuronetics Inc/

Recent news which mentions Neuronetics Inc/

Lab Notes: CHOP gets $10M research gift; Vallon seeks greater shareholder support for merger
Tickers INNO
Tags Neuronetics Inc/ Keith J/ Sullivan David Baker
From Business Journals
Lab Notes: Neuronetics resolves lawsuit; Harmony CEO departs; Ocugen issues results of Covaxin study
Tickers INNO
Tags AstraZeneca PLC Roundup Christopher von Jako
From Business Journals
Lab Notes: FDA approves Incyte's vitiligo treatment; Neuronetics gets a 'big win'
Tickers INNO
Tags Arbutus Biopharma Corporation Nabriva Therapeutics plc Ireland Keith J/Sullivan
From Business Journals
Neuronetics gets FDA approval for wider use of its NeuroStar treatment system
Tags Insurance Keith J/ Sullivan Cory Anderson
From Business Journals
Lab Notes: Endo acquires 6 product candidates for $35M; NiKang signs deal worth up to $218M
Tickers INNO
Tags Endo International plc Virpax Pharmaceuticals Inc/ Inno
From Business Journals
Lab Notes: Oncora Medical doubles its client base; Context Therapeutics posts promising cancer drug data
Tickers INNO
Tags Chris Garabedian Health Care Joshua Asper
From Business Journals
Lab Notes: Imvax presents new data on lead drug candidate; Neuronetics forms new partnership
Tickers INNO
Tags Ted Schroeder Keith J/ Sullivan Health Care
From Business Journals
Lab Notes: NFlection names new CEO; Immunocore enters into cancer drug partnership
Tickers INNO
Tags Libbie Mansell Neuronetics, Inc/ Insurance
From Business Journals